menu
    • menu

    Company profile for Totus Medicines

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Totus Medicines’ drug discovery capabilities put the company in a position to upend the traditional processes, creating new drug programs with exquisite precision and unprecedented efficiency.We’re a group of cross-disciplinary scientists and profession­als working together to bring hope to every diagnosis

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Totus MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    700 Main St, Cambridge, Massachusetts 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.totusmedicines.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/totusmedicines/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/totustx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Totus Presents Phase 1a TOS-358 Data at ESMO TAT 2026
    Totus Presents Phase 1a TOS-358 Data at ESMO TAT 2026

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258423/0/en/Totus-Medicines-Presents-Phase-1a-Clinical-Data-for-TOS-358-a-Covalent-PI3Ka-Inhibitor-at-ESMO-TAT-2026.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Totus Medicines To Unveil TOS-358 Phase 1 Data At ESMO 2026
    Totus Medicines To Unveil TOS-358 Phase 1 Data At ESMO 2026

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237131/0/en/Totus-Medicines-to-Present-Updated-Phase-1-Clinical-Data-for-TOS-358-at-ESMO-Targeted-Anticancer-Therapies-Congress-2026.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Totus Medicines at 44th Annual J.P. Morgan Healthcare Conference
    Totus Medicines at 44th Annual J.P. Morgan Healthcare Conference

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213569/0/en/Totus-Medicines-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Totus Medicines Appoints Simon Harnest as Chief Financial Officer
    Totus Medicines Appoints Simon Harnest as Chief Financial Officer

    28 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/28/3016305/0/en/Totus-Medicines-Appoints-Simon-Harnest-MSc-BSc-as-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    28 Jan 2025
    Share Share
    Totus Completes Ph 1 Study Of TOS-358, Appoints Zelanna CMO
    Totus Completes Ph 1 Study Of TOS-358, Appoints Zelanna CMO

    10 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/10/3007658/0/en/Totus-Medicines-Announces-Successful-Completion-of-a-Phase-1-Dose-Escalation-Study-and-Initiation-of-an-Expansion-Trial-Evaluating-TOS-358-a-Covalent-PI3Ka-Selective-Therapy-for-th.html

    GLOBENEWSWIRE
    10 Jan 2025
    Share Share
    Totus Medicines, Lilly Announce Multi-Target Research Collaboration
    Totus Medicines, Lilly Announce Multi-Target Research Collaboration

    16 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/16/2883334/0/en/Totus-Medicines-Announces-Strategic-Multi-Target-Research-Collaboration-with-Lilly.html

    GLOBENEWSWIRE
    16 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search